
Ocular Therapeutics Conference is back!
The only New Zealand meeting focused entirely on ocular therapeutics, the Ocular Therapeutics Conference (OTC), returns on 14 September for a day of translational research and practical learning. Re

The only New Zealand meeting focused entirely on ocular therapeutics, the Ocular Therapeutics Conference (OTC), returns on 14 September for a day of translational research and practical learning. Re

Researchers in the Molecular Vision Research Cluster (MVRC) at the University of Auckland are calling for eyecare professionals to refer a specific cohort of patients for a study they hope will result in new treatments for cataract and presbyopia.

The end of the first phase of the Shared Digital Health Record (SDHR), intended to enhance and increase coverage of existing regional shared electronic health records (SEHRs), is now scheduled for Dec

Just two days after the Retinalogik AI-based virtual reality (VR) system reached New Zealand shores it was on display on Medix21’s stand at the RANZCO NZ 2025 conference, ready to wow eyecare professi

The largest study of the iStent inject W trabecular micro-bypass combined with cataract surgery for Asian eyes with glaucoma found it reduced intraocular pressure (IOP) and halved medication costs. Th

A world-first ultra-widefield eye imaging study in adults with Down syndrome found that abnormal blood vessels in the retinal periphery are visible before clinical symptoms of Alzheimer’s disease begi

Korean researchers found larger corneal hysteresis changes in patients with early-to-moderate open-angle glaucoma (OAG) indicate a higher risk of glaucoma progression in those with a history of laser

Ocugen announced the US Food and Drug Administration (FDA) has granted rare paediatric disease designation for OCU410ST, the company’s gene therapy for ABCA4-associated retinopathies including Stargar

The number of people diagnosed with multiple sclerosis (MS) in New Zealand increased by a third between 2006 and 2022, according to new research by the University of Auckland. Led by Dr Natalia Bove

The team behind the Vision Bus Aotearoa (VBA) is seeking new funding to support continued mobile eyecare service delivery to underserved schools, primarily in the South Auckland region. Funded entir

An international study found metastasis occurred in 10% of conjunctival melanoma patients, with the liver and lungs the most commonly reported sites (45% each). A total of 288 patients with conjunct

Taking pride of place on Ophthalmic Instrument Company’s (OIC’s) stand at RANZCO NZ was the new Reticam 3100 Plus, an ultra-widefield (UWF) retinal camera from SysEye.